Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times

GlaxoSmithKline transfer pricing case settled

Generic drugs – All About Drugs, generic

Why Glaxo Won't Pay Doctors To Sell Its Drugs Anymore : Shots - Health News : NPR

UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg

China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case - The New York Times

GlaxoSmithKline (GLAXF) - I'm Not Buying It (Yet)

GlaxoSmithKline's bribes are evidence that Big Pharma isn't working, Philip Ball

Generic drugs in the US are too cheap to be sustainable, experts say, Drugs

A 29-year-old former Wall Streeter bought an Alzheimer's drug that failed clinical trials — and now his company is worth $3 billion

These were the biggest pharmaceutical deals in early 2022 - Pharmaceutical Technology

Generic drugs – All About Drugs, generic

How Public Opinion Polls Expand the Conversation on GSK v. Teva and Skinny Labeling

The top 10 drugs losing US exclusivity in 2023

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition - The New York Times

Drug Company 'Shenanigans' to Block Generics Come Under Federal Scrutiny - The New York Times